About ImmuCell Corp.

ImmuCell Corp. engages in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include first defense for scours, California mastitis test kit and purified nisin intramammary treatment for mastitis. The company was founded in 1982 and is headquartered in Portland, ME.

At the moment the company generates 11M USD in revenues.

On its last earning announcement, the company reported a loss of -0.27$ per share.

The book value per share is 4.16$

ImmuCell Corp. website


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
11M 44.80% -2M -14.60% -1M -0.27 - - 5M 4.16 - -7M -7M